{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:03:45Z","timestamp":1792785825023,"version":"4.5.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS097197"],"award-info":[{"award-number":["P01NS097197"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR180056"],"award-info":[{"award-number":["RR180056"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jimmy Elizabeth Wescott Chair in Pediatric Neurology"},{"name":"University of Texas Southwestern"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lafora disease is a fatal teenage-onset progressive myoclonus epilepsy and neurodegenerative disease associated with polyglucosan bodies. Polyglucosans are long-branched and as a result precipitation- and aggregation-prone glycogen. In mouse models, downregulation of glycogen synthase, the enzyme that elongates glycogen branches, prevents polyglucosan formation and rescues Lafora disease. Mouse work, however, has not yet revealed the mechanisms of polyglucosan generation, and few in vivo human studies have been performed. Here, non-invasive in vivo magnetic resonance spectroscopy (1H and 31P) was applied to test scan feasibility and assess neurotransmitter balance and energy metabolism in Lafora disease towards a better understanding of pathogenesis. Macromolecule-suppressed gamma-aminobutyric acid (GABA)-edited 1H magnetic resonance spectroscopy and 31P magnetic resonance spectroscopy at 3 and 7 tesla, respectively, were performed in 4 Lafora disease patients and a total of 21 healthy controls (12 for the 1H magnetic resonance spectroscopy and 9 for the 31PMRS). Spectra were processed using in-house software and fit to extract metabolite concentrations. From the 1H spectra, we found 33% lower GABA concentrations (P = 0.013), 34% higher glutamate + glutamine concentrations (P = 0.011) and 24% lower N-acetylaspartate concentrations (P = 0.0043) in Lafora disease patients compared with controls. From the 31P spectra, we found 34% higher phosphoethanolamine concentrations (P = 0.016), 23% lower nicotinamide adenine dinucleotide concentrations (P = 0.003), 50% higher uridine diphosphate glucose concentrations (P = 0.004) and 225% higher glucose 6-phosphate concentrations in Lafora disease patients versus controls (P = 0.004). Uridine diphosphate glucose is the substrate of glycogen synthase, and glucose 6-phosphate is its extremely potent allosteric activator. The observed elevated uridine diphosphate glucose and glucose 6-phosphate levels are expected to hyperactivate glycogen synthase and may underlie the generation of polyglucosans in Lafora disease. The increased glutamate + glutamine and reduced GABA indicate altered neurotransmission and energy metabolism, which may contribute to the disease\u2019s intractable epilepsy. These results suggest a possible basis of polyglucosan formation and potential contributions to the epilepsy of Lafora disease. If confirmed in larger human and animal model studies, measurements of the dysregulated metabolites by magnetic resonance spectroscopy could be developed into non-invasive biomarkers for clinical trials.<\/jats:p>","DOI":"10.1093\/braincomms\/fcae104","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T19:02:12Z","timestamp":1711134132000},"source":"Crossref","is-referenced-by-count":8,"title":["1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-2073","authenticated-orcid":false,"given":"Kimberly L","family":"Chan","sequence":"first","affiliation":[{"name":"Advanced Imaging Research Center, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"},{"name":"Department of Psychiatry, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Panatpur","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Texas Children\u2019s Hospital, Baylor College of Medicine , Houston, TX 77030 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Messahel","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Pediatrics, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Dahshi","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Pediatrics, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4994-215X","authenticated-orcid":false,"given":"Talon","family":"Johnson","sequence":"additional","affiliation":[{"name":"Advanced Imaging Research Center, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Henning","sequence":"additional","affiliation":[{"name":"Advanced Imaging Research Center, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"},{"name":"Department of Radiology, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-8447","authenticated-orcid":false,"given":"Jimin","family":"Ren","sequence":"additional","affiliation":[{"name":"Advanced Imaging Research Center, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"},{"name":"Department of Radiology, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berge A","family":"Minassian","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Pediatrics, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"2024043010203834600_fcae104-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02863929","article-title":"Beitrag zur histopathologie der myoklonischen epilepsie","volume":"6","author":"Lafora","year":"1911","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie"},{"issue":"4","key":"2024043010203834600_fcae104-B2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neurol.2021.06.006","article-title":"Lafora disease: Current biology and therapeutic approaches","volume":"178","author":"Mitra","year":"2022","journal-title":"Rev Neurol (Paris)"},{"issue":"41","key":"2024043010203834600_fcae104-B3","doi-asserted-by":"crossref","first-page":"30412","DOI":"10.1074\/jbc.M606117200","article-title":"Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates","volume":"281","author":"Worby","year":"2006","journal-title":"J Biol Chem"},{"issue":"49","key":"2024043010203834600_fcae104-B4","doi-asserted-by":"crossref","first-page":"19262","DOI":"10.1073\/pnas.0707952104","article-title":"Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo","volume":"104","author":"Tagliabracci","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2024043010203834600_fcae104-B5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.15252\/emmm.201707608","article-title":"Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease","volume":"9","author":"Nitschke","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2024043010203834600_fcae104-B6","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049802","article-title":"Laforin targets malin to glycogen in lafora progressive myoclonus epilepsy","volume":"16","author":"Mitra","year":"2023","journal-title":"Dis Model Mech"},{"issue":"24","key":"2024043010203834600_fcae104-B7","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","article-title":"Insights into Lafora disease: Malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin","volume":"102","author":"Gentry","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2024043010203834600_fcae104-B8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ana.23899","article-title":"Inhibiting glycogen synthesis prevents Lafora disease in a mouse model","volume":"74","author":"Pederson","year":"2013","journal-title":"Ann Neurol"},{"issue":"12","key":"2024043010203834600_fcae104-B9","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease","volume":"23","author":"Duran","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2024043010203834600_fcae104-B10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting gys1 with AAV-SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2024043010203834600_fcae104-B11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cmet.2019.07.002","article-title":"Targeting pathogenic lafora bodies in lafora disease using an antibody-enzyme fusion","volume":"30","author":"Brewer","year":"2019","journal-title":"Cell Metab"},{"issue":"7","key":"2024043010203834600_fcae104-B12","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.3390\/ijms24076020","article-title":"Deciphering the polyglucosan accumulation present in lafora disease using an astrocytic cellular model","volume":"24","author":"Moreno-Estelles","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024043010203834600_fcae104-B13","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mrm.28950","article-title":"Improved prospective frequency correction for macromolecule-suppressed GABA editing with metabolite cycling at 3T","volume":"86","author":"Chan","year":"2021","journal-title":"Magn Reson Med"},{"issue":"1","key":"2024043010203834600_fcae104-B14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/mrm.25094","article-title":"Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain","volume":"73","author":"Near","year":"2015","journal-title":"Magn Reson Med"},{"issue":"6","key":"2024043010203834600_fcae104-B15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jmri.24478","article-title":"Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra","volume":"40","author":"Edden","year":"2014","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2024043010203834600_fcae104-B16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"issue":"1","key":"2024043010203834600_fcae104-B17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/mrm.26091","article-title":"Advanced processing and simulation of MRS data using the FID appliance (FID-A)-an open source, MATLAB-based toolkit","volume":"77","author":"Simpson","year":"2017","journal-title":"Magn Reson Med"},{"issue":"11","key":"2024043010203834600_fcae104-B18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/nbm.3384","article-title":"(31)P-MRS of healthy human brain: ATP synthesis, metabolite concentrations, pH, and T1 relaxation times","volume":"28","author":"Ren","year":"2015","journal-title":"NMR Biomed"},{"issue":"4","key":"2024043010203834600_fcae104-B19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/mrm.22708","article-title":"Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: Validation in the cerebellum and brainstem","volume":"65","author":"Oz","year":"2011","journal-title":"Magn Reson Med"},{"issue":"2","key":"2024043010203834600_fcae104-B20","doi-asserted-by":"crossref","first-page":"e4836","DOI":"10.1002\/nbm.4836","article-title":"ATP line splitting in association with reduced intracellular magnesium and pH: A brain (31) P MR spectroscopic imaging (MRSI) study of pediatric patients with myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGADs)","volume":"36","author":"Ren","year":"2023","journal-title":"NMR Biomed"},{"issue":"7","key":"2024043010203834600_fcae104-B21","doi-asserted-by":"crossref","first-page":"e4511","DOI":"10.1002\/nbm.4511","article-title":"(31) P-MRS of the healthy human brain at 7 T detects multiple hexose derivatives of uridine diphosphate glucose","volume":"34","author":"Ren","year":"2021","journal-title":"NMR Biomed"},{"issue":"4","key":"2024043010203834600_fcae104-B22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1167.2006.00526.x","article-title":"MRI volumetry and proton MR spectroscopy of the brain in Lafora disease","volume":"47","author":"Villanueva","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"2024043010203834600_fcae104-B23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejpn.2007.09.008","article-title":"Lafora disease: Spectroscopy study correlated with neuropsychological findings","volume":"12","author":"Pichiecchio","year":"2008","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"2024043010203834600_fcae104-B24","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/jvim.15799","article-title":"Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease","volume":"34","author":"Alisauskaite","year":"2020","journal-title":"J Vet Intern Med"},{"issue":"6","key":"2024043010203834600_fcae104-B25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.410440604","article-title":"Adult polyglucosan body disease in ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene","volume":"44","author":"Lossos","year":"1998","journal-title":"Ann Neurol"},{"issue":"12","key":"2024043010203834600_fcae104-B26","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/nbm.3045","article-title":"Glutamate and glutamine: A review of in vivo MRS in the human brain","volume":"26","author":"Ramadan","year":"2013","journal-title":"NMR Biomed"},{"issue":"3","key":"2024043010203834600_fcae104-B27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed"},{"issue":"6","key":"2024043010203834600_fcae104-B28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbadis.2016.03.008","article-title":"Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease","volume":"1862","author":"Munoz-Ballester","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2024043010203834600_fcae104-B29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/glia.23956","article-title":"Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease","volume":"69","author":"Perez-Jimenez","year":"2021","journal-title":"Glia"},{"issue":"11","key":"2024043010203834600_fcae104-B30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/emmm.201100174","article-title":"Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease","volume":"3","author":"Valles-Ortega","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"13","key":"2024043010203834600_fcae104-B31","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1074\/jbc.M112.416180","article-title":"Neuronatin-mediated aberrant calcium signaling and endoplasmic reticulum stress underlie neuropathology in Lafora disease","volume":"288","author":"Sharma","year":"2013","journal-title":"J Biol Chem"},{"key":"2024043010203834600_fcae104-B32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-6606-7-7","article-title":"Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease","volume":"7","author":"Ortolano","year":"2014","journal-title":"Mol Brain"},{"issue":"24","key":"2024043010203834600_fcae104-B33","doi-asserted-by":"crossref","first-page":"16255","DOI":"10.1016\/S0021-9258(18)98543-1","article-title":"Nucleotide sequence of the fadA gene. Primary structure of 3-ketoacyl-coenzyme A thiolase from Escherichia coli and the structural organization of the fadAB operon","volume":"266","author":"Yang","year":"1991","journal-title":"J Biol Chem"},{"issue":"5","key":"2024043010203834600_fcae104-B34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1528-1167.2008.01948.x","article-title":"Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy","volume":"50","author":"Lin","year":"2009","journal-title":"Epilepsia"},{"key":"2024043010203834600_fcae104-B35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.seizure.2021.06.028","article-title":"Brain concentrations of glutamate and GABA in human epilepsy: A review","volume":"91","author":"Sarlo","year":"2021","journal-title":"Seizure"},{"issue":"4","key":"2024043010203834600_fcae104-B36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1528-1157.2003.19102.x","article-title":"A proton magnetic resonance spectroscopy study of metabolites in the occipital lobes in epilepsy","volume":"44","author":"Simister","year":"2003","journal-title":"Epilepsia"},{"issue":"6","key":"2024043010203834600_fcae104-B37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1212\/WNL.56.6.709","article-title":"Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures","volume":"56","author":"Petroff","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"2024043010203834600_fcae104-B38","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/epi.12656","article-title":"Frontal and thalamic changes of GABA concentration indicate dysfunction of thalamofrontal networks in juvenile myoclonic epilepsy","volume":"55","author":"Hattingen","year":"2014","journal-title":"Epilepsia"},{"issue":"1","key":"2024043010203834600_fcae104-B39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuroimage.2003.08.034","article-title":"MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies","volume":"21","author":"Savic","year":"2004","journal-title":"Neuroimage"},{"issue":"3","key":"2024043010203834600_fcae104-B40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3348\/kjr.2006.7.3.162","article-title":"Structural brain abnormalities in juvenile myoclonic epilepsy patients: Volumetry and voxel-based morphometry","volume":"7","author":"Tae","year":"2006","journal-title":"Korean J Radiol"},{"issue":"3","key":"2024043010203834600_fcae104-B41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1528-1157.2000.tb00158.x","article-title":"MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy","volume":"41","author":"Savic","year":"2000","journal-title":"Epilepsia"},{"issue":"49","key":"2024043010203834600_fcae104-B42","doi-asserted-by":"crossref","first-page":"33816","DOI":"10.1074\/jbc.M807428200","article-title":"Abnormal metabolism of glycogen phosphate as a cause for Lafora disease","volume":"283","author":"Tagliabracci","year":"2008","journal-title":"J Biol Chem"},{"issue":"33","key":"2024043010203834600_fcae104-B43","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","article-title":"Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin","volume":"285","author":"DePaoli-Roach","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"2024043010203834600_fcae104-B44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BJ20111416","article-title":"Glycogen and its metabolism: Some new developments and old themes","volume":"441","author":"Roach","year":"2012","journal-title":"Biochem J"},{"issue":"4","key":"2024043010203834600_fcae104-B45","doi-asserted-by":"crossref","first-page":"100455","DOI":"10.1016\/j.crmeth.2023.100455","article-title":"In situ microwave fixation provides an instantaneous snapshot of the brain metabolome","volume":"3","author":"Juras","year":"2023","journal-title":"Cell Rep Methods"},{"issue":"6","key":"2024043010203834600_fcae104-B46","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mrm.26456","article-title":"Detection of glucose in the human brain with (1) H MRS at 7 tesla","volume":"76","author":"Kaiser","year":"2016","journal-title":"Magn Reson Med"},{"issue":"4","key":"2024043010203834600_fcae104-B47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00004647-200004000-00011","article-title":"Extracellular-intracellular distribution of glucose and lactate in the rat brain assessed noninvasively by diffusion-weighted 1H nuclear magnetic resonance spectroscopy in vivo","volume":"20","author":"Pfeuffer","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"2024043010203834600_fcae104-B48","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1177\/0271678X221104540","article-title":"Measurement of glucose metabolism in the occipital lobe and frontal cortex after oral administration of [1\u201313C]glucose at 9.4 T","volume":"42","author":"Ziegs","year":"2022","journal-title":"J Cereb Blood Flow Metab"},{"key":"2024043010203834600_fcae104-B49","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.nbd.2023.105998","article-title":"P-Rex1 is a novel substrate of the E3 ubiquitin ligase malin associated with Lafora disease","volume":"177","author":"Kumarasinghe","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"Pt 5","key":"2024043010203834600_fcae104-B50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/124.5.953","article-title":"Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis","volume":"124","author":"Mader","year":"2001","journal-title":"Brain"},{"issue":"12","key":"2024043010203834600_fcae104-B51","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1161\/hs1201.099414","article-title":"Spectroscopic assessment of alterations in macromolecule and small-molecule metabolites in human brain after stroke","volume":"32","author":"Graham","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"2024043010203834600_fcae104-B52","doi-asserted-by":"crossref","first-page":"e4393","DOI":"10.1002\/nbm.4393","article-title":"Contribution of macromolecules to brain (1) H MR spectra: Experts\u2019 consensus recommendations","volume":"34","author":"Cudalbu","year":"2021","journal-title":"NMR Biomed"},{"key":"2024043010203834600_fcae104-B53","doi-asserted-by":"crossref","first-page":"800273","DOI":"10.3389\/fimmu.2022.800273","article-title":"A neurometabolic pattern of elevated myo-inositol in children who are HIV-exposed and uninfected: A South African birth cohort study","volume":"13","author":"Bertran-Cobo","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"2024043010203834600_fcae104-B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem Res"},{"issue":"6","key":"2024043010203834600_fcae104-B55","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/brainsci12060802","article-title":"High myoinositol on proton MR spectroscopy could be a potential signature of papillary tumors of the pineal region-case report of two patients","volume":"12","author":"Pons-Escoda","year":"2022","journal-title":"Brain Sci"},{"issue":"12","key":"2024043010203834600_fcae104-B56","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3800","article-title":"Simultaneous detection of glutathione and lactate using spectral editing at 3 T","volume":"30","author":"Chan","year":"2017","journal-title":"NMR Biomed"},{"key":"2024043010203834600_fcae104-B57","doi-asserted-by":"crossref","first-page":"e62575","DOI":"10.7554\/eLife.62575","article-title":"The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies","volume":"10","author":"Porges","year":"2021","journal-title":"Elife"},{"issue":"4","key":"2024043010203834600_fcae104-B58","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/jon.12514","article-title":"Effects of aging on the human brain: A proton and phosphorus MR spectroscopy study at 3T","volume":"28","author":"Schmitz","year":"2018","journal-title":"J Neuroimaging"},{"key":"2024043010203834600_fcae104-B59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neubiorev.2019.01.003","article-title":"Neurochemical changes in the aging brain: A systematic review","volume":"98","author":"Cleeland","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"2024043010203834600_fcae104-B60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neurobiolaging.2020.07.015","article-title":"A quantitative meta-analysis of brain glutamate metabolites in aging","volume":"95","author":"Roalf","year":"2020","journal-title":"Neurobiol Aging"},{"key":"2024043010203834600_fcae104-B61","article-title":"Revealing hidden phosphomonoester signals under phosphoethanolamine and phosphocholine resonances: A brain 31P MRS study at 7T","author":"Ren","year":"2023","journal-title":"Int Soc Magn Reson Med"},{"issue":"4","key":"2024043010203834600_fcae104-B62","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI115686","article-title":"31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus","volume":"89","author":"Rothman","year":"1992","journal-title":"J Clin Invest"},{"issue":"8","key":"2024043010203834600_fcae104-B63","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/cells8080890","article-title":"Regulation of glucose metabolism by NAD(+) and ADP-ribosylation","volume":"8","author":"Hopp","year":"2019","journal-title":"Cells"},{"issue":"4","key":"2024043010203834600_fcae104-B64","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1750-3639.2009.00308.x","article-title":"22-Year-old girl with status epilepticus and progressive neurological symptoms","volume":"19","author":"Striano","year":"2009","journal-title":"Brain Pathol"},{"issue":"1","key":"2024043010203834600_fcae104-B65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0370-4475(78)80126-9","article-title":"[Lafora disease (author's transl)]","volume":"8","author":"Tassinari","year":"1978","journal-title":"Rev Electroencephalogr Neurophysiol Clin"},{"issue":"2-3","key":"2024043010203834600_fcae104-B66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eplepsyres.2010.01.006","article-title":"Short and long interval cortical inhibition in patients with unverricht-lundborg and lafora body disease","volume":"89","author":"Canafoglia","year":"2010","journal-title":"Epilepsy Res"},{"issue":"6","key":"2024043010203834600_fcae104-B67","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1388-2457(03)00066-X","article-title":"Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models","volume":"114","author":"Panzica","year":"2003","journal-title":"Clin Neurophysiol"},{"issue":"12","key":"2024043010203834600_fcae104-B68","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1212\/01.WNL.0000147475.71345.AA","article-title":"Sensorimotor cortex excitability in unverricht-lundborg disease and lafora body disease","volume":"63","author":"Canafoglia","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"2024043010203834600_fcae104-B69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.25867","article-title":"The role of the cerebellum in the pathogenesis of cortical myoclonus","volume":"29","author":"Ganos","year":"2014","journal-title":"Mov Disord"},{"key":"2024043010203834600_fcae104-B70","article-title":"Preliminary study of a lafora disease mouse model using glycoNOE MRI","author":"Bie","year":"2021","journal-title":"Int Soc Magn Reson Med"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcae104\/57089631\/fcae104.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/2\/fcae104\/57292959\/fcae104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/2\/fcae104\/57292959\/fcae104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T06:21:50Z","timestamp":1714458110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcae104\/7634870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcae104","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"fcae104"}}